Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
BrightHeart logo — Advancing prenatal ultrasound screening with AI

BrightHeart

Advancing prenatal ultrasound screening with AI

Founded 2020 France France 16 employees Seed Total: $2.00M Health Care, Medical Devices

General Information

Company Name BrightHeart
Founded Year 2020
Location France France
Employees 16
Industries Health Care, Medical Devices
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with BrightHeart. To contact BrightHeart, visit brightheart.fr.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BrightHeart compare?

A PDF of BrightHeart and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BrightHeart soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BrightHeart

BrightHeart is a France-based startup that is revolutionizing prenatal ultrasound screening through the integration of AI. Its slogan "Advancing prenatal ultrasound screening with AI" encapsulates the company's mission to ensure that every fetal ultrasound screening exam is conducted with the utmost accuracy, thereby ensuring the highest possible quality of care for both the mother and the baby.

Founded in 2020, BrightHeart operates within the Health Care and Medical Devices industries, focusing on bringing cutting-edge technology to the field of prenatal care.

The company recently secured a significant boost with a €2.00MSeed Round investment on 31 May 2023. This investment was led by Sofinnova Partners, signifying strong support and confidence from this reputable investor in BrightHeart's vision and potential.

With its innovative approach and recent investment, BrightHeart is poised to make meaningful contributions to the improvement of prenatal care, leveraging AI to enhance the accuracy and efficacy of fetal ultrasound screenings.

Business keywords: Prenatal ultrasound screening, Medical technology, Artificial intelligence, Congenital heart abnormalities diagnosis, Fetal ultrasound exams, Diagnostic imaging, Maternal and fetal care, AI in healthcare, Medical software development

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round €2.00M 1
Sofinnova Partners
Sofinnova Partners
31 May 2023

BrightHeart Alternatives & Competitors

View All Alternatives
BrightHeart vs
Sonio
Sonio United States

Securing pregnancy care

Acquired
110 employees
AI, Health Care
Compare BrightHeart vs Sonio
BrightHeart vs
Origin Medical Research Lab
Origin Medical Research Lab India

Creating leading AI in healthcare with best-in-class technologists

Venture round
53 employees
Health Care, Medical Devices
BrightHeart vs
Medo.ai
Medo.ai Canada

Ultrasound made simple.

Convertible Note
6 employees
AI, Biotechnology
View all alternatives

FAQ About BrightHeart

Advancing prenatal ultrasound screening with AI
BrightHeart was founded in 2020.
BrightHeart is headquartered in France.
BrightHeart operates in Health Care and Medical Devices. Its work centres on Prenatal ultrasound screening, Medical technology, Artificial intelligence and Congenital heart abnormalities diagnosis.
BrightHeart has approximately 16 employees.
BrightHeart has completed 1 funding round, raising a total of $2.00M. The latest funding stage is Seed.
Top alternatives and competitors to BrightHeart include Sonio, Origin Medical Research Lab, Medo.ai, Northh Medical GmbH, Elizabeth Wende Breast Care. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BrightHeart and Sonio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BrightHeart, https://bouncewatch.com/company/brightheart-1, updated 7 June 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes